Sign in
CKDXF Stock Price, Chart, Stats & News
Ceryvyn Therapeutics Limited
Save
Ceryvyn Therapeutics Limited (CKDXF) does not currently pay a dividend.
13.68M
Market cap
–
Current P/E
5.99x
Forward P/E
CKDXF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Ceryvyn Therapeutics Ltd is a clinical-stage biopharmaceutical company developing therapies for the rare lung disease lymphangioleiomyomatosis (LAM). Its lead program, CYV-101, is a fusion protein designed to neutralize VEGF-C and VEGF-D, key signaling proteins involved in the disease. The company was formerly known as Opthea Limited.
Similar securities
Based on sector and market capitalization
Report issue